You are here

  • Home
  • Archive
  • Volume 83, Issue Suppl 1
  • POS0727 VALIDATION OF 2023 ACR/EULAR ANTIPHOSPHOLIPID SYNDROME CLASSIFICATION CRITERIA IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND POSITIVE ANTIPHOSPHOLIPID ANTIBODIES

Article info

Article menu
Download PDFPDF
Scientific Abstracts
Poster View
Antiphospholipid syndrome
POS0727 VALIDATION OF 2023 ACR/EULAR ANTIPHOSPHOLIPID SYNDROME CLASSIFICATION CRITERIA IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND POSITIVE ANTIPHOSPHOLIPID ANTIBODIES

Authors

Citation

Koliadenko D, Iaremenko O
POS0727 VALIDATION OF 2023 ACR/EULAR ANTIPHOSPHOLIPID SYNDROME CLASSIFICATION CRITERIA IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND POSITIVE ANTIPHOSPHOLIPID ANTIBODIES
Annals of the Rheumatic Diseases 2024;83:542-543.

Publication history

  • First published June 10, 2024.
Online issue publication 
June 10, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.